Screener
BioCryst Pharmaceuticals BCRX EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Foreign currency translation adjustment | (27) | 702 | (89) | 1,068 |
| Unrealized loss on available for sale investments | (133) | (188) | (477) | (343) |
| Total other comprehensive (loss) income | (160) | 514 | (566) | 725 |
| Net comprehensive income (loss) | $78,235 | $5,599 | $(643,983) | $5,842 |
| Net income (loss) per common share: basic | $0.31 | $0.02 | $(2.59) | $0.02 |
| Weighted average shares of common stock outstanding: basic | 254,481 | 209,519 | 248,403 | 209,203 |
| Net income (loss) per common share: diluted | $0.30 | $0.02 | $(2.59) | $0.02 |
| Weighted average shares of common stock outstanding: diluted | 265,165 | 219,886 | 248,403 | 217,574 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is BioCryst Pharmaceuticals's EPS (basic)?
- BioCryst Pharmaceuticals (BCRX) reported EPS (basic) of $0.31 in Q2 2026.
- How has BioCryst Pharmaceuticals's EPS (basic) changed year-over-year?
- BioCryst Pharmaceuticals's EPS (basic) increased by 1450.0% year-over-year, from $0.02 to $0.31.
- What is the long-term trend for BioCryst Pharmaceuticals's EPS (basic)?
- Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's EPS (basic) has grown at a 5.0% compound annual growth rate (CAGR), from -$1.03 to $1.25.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about BioCryst Pharmaceuticals's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude